Table 1 Clinical Characteristics of Newly Diagnosed AML Patients
From: INPP4B promotes cell survival via SGK3 activation in NPM1-mutated leukemia
Characteristics | Median (range) | No. of cases |
|---|---|---|
Sex | ||
 Female |  | 19 |
 Male |  | 17 |
 Total |  | 36 |
Age | ||
 Median, years | 53.8 (26–79) |  |
WBC | ||
 Median, ×109/L | 44 (0.3–295.0) |  |
Platelets | ||
 Median, ×109/L | 57.3 (3.0–655.0) |  |
AML FAB subtype | ||
 AML without maturation: M1 |  | 4 |
 AML with maturation: M2 |  | 6 |
 Acute promyelocytic leukemia: M3 |  | 9 |
 Acute myelomonocytic leukemia: M4 |  | 7 |
 Acute monoblastic or monocytic leukemia: M5 |  | 9 |
 Other subtype |  | 1 |
Karyotype | ||
 Normal |  | 14 |
 t (8;21) |  | 5 |
 t (15;17) |  | 6 |
 inv. (16) |  | 7 |
 Unknown |  | 4 |
Gene mutations | ||
 NPM1 |  | 14 |
 FLT3-ITD |  | 10 |
 WT1 |  | 9 |
 CBFB-MYH11 |  | 5 |